BioSpace News Archive

On December 3, 2020, Luminex Corporation, announced that its board of directors approved a $0.01 increase in the quarterly dividend, to $0.10 per share of common stock, payable on January 14, 2021 to stockholders of record as of the close of business December 23, 2021.

Our perceptions of the world are shaped both by our biology and our experiences. New work from Cold Spring Harbor Laboratory Adjunct Professor Z. Josh Huang provides a glimpse of how these factors intersect in a part of the brain that integrates visual information, establishing the neural circuitry that literally shapes how we see the world.

Peer-reviewed publication demonstrates that Boltbody ISAC treatment leads to complete clearance of large HER2-expressing tumors and protective immunological memory in preclinical models

Companies combining their key strengths to provide enhanced integrated workflow software solution designed to provide superior infection prevention and practice optimization

Biosero, Inc. and Elemental Machines will integrate Biosero’s Green Button Go™ Automation Scheduling Software with Elemental Machines’ AI-powered platform so scientists and researchers can produce consistent, reliable results from every life science laboratory experiment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201207005034/en/

Companies combining their key strengths to provide enhanced integrated workflow software solution designed to provide superior infection prevention and practice optimization

CVS Health is reminding everyone that it’s not too late to get a flu shot, as the country marks National Influenza Vaccination Week.

DURECT Corporation (Nasdaq: DRRX) today announced that it has signed an agreement to sell its LACTEL Absorbable Polymer (LACTEL) product line to Evonik, a global leader in specialty chemicals. Under the terms of the agreement, Evonik will pay DURECT $15 million in exchange for certain assets and liabilities associated with

Medline and VitalTech announced an exclusive agreement to bring virtual care and remote patient monitoring solutions to the physician office market throughout the U.S. Telehealth adoption and usage by healthcare providers has grown significantly to offset a nearly 70% drop in in-person health care office visits.

Immunovia AB (publ) (“Immunovia”) a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray™ for the early detection of cancer, announced today that Julie Silber , Senior Director of Investor Relations has stepped down from her position to pursue other